Scientists have created the most comprehensive method yet to predict a woman’s risk of breast cancer, according to a study led by researchers at the University of Cambridge. The study, funded by Cancer Research, is published today in Genetics in Medicine.
It could be a game changer for breast cancer because now we can identify large numbers of women with different levels of risk – not just women who are at high risk
They have a developed a way of calculating the risk of developing the disease by combining information on family history and genetics with other factors such as weight, age at menopause, alcohol consumption and use of hormone replacement therapy.
Although individually some of these things have a small impact on the likelihood of developing the disease, researchers found that by considering all of them at once, plus family history and genetics, they can identify groups of women who have different risks of developing breast cancer.
Importantly, for the first time, researchers have taken into account more than 300 genetic indicators for breast cancer. This makes calculating the risk much more precise than ever before.
From this, the researchers have created an online calculator for GPs to use in their surgeries.
Some GPs, practice nurses and genetic counsellors are testing this tool before it is considered for wider use. Doctors are prompted to answer a series of online questions about their patient including their medical and family history, whether they have any known genetic alterations linked to cancer, their weight and whether they drink alcohol.
In the future, information like this could help to tailor breast cancer screening depending on an individual’s risk. For example, it could help determine what age they are first invited for breast screening or how regularly they are invited to receive it.
The risk calculation could also help people to make decisions about preventative therapy – such as identifying women at high risk who may benefit from taking the drug tamoxifen – as well as encouraging women to think about the ways they could reduce the risk themselves, for example trying to keep a healthy weight.
Professor Antonis Antoniou, lead author at the Department of Public Health and Primary Care, University of Cambridge, said: “This is the first time that anyone has combined so many elements into one breast cancer prediction tool. It could be a game changer for breast cancer because now we can identify large numbers of women with different levels of risk – not just women who are at high risk.
“This should help doctors to tailor the care they provide depending on their patients’ level of risk. For example, some women may need additional appointments with their doctor to discuss screening or prevention options and others may just need advice on their lifestyle and diet.
“We hope this means more people can be diagnosed early and survive their disease for longer, but more research and trials are needed before we will fully understand how this could be used.”
Breast cancer is the most common cancer in the UK. Nearly 55,000 women are diagnosed with the disease each year. But a large proportion of breast cancer cases occur in people who are at an increased risk. Cancer Research UK has helped to double breast cancer survival over the last 40 years.
Dr Richard Roope, Cancer Research UK’s GP expert, said: “Research like this is hugely exciting because in the future it will enable us to offer much more tailored care which will benefit patients and make best use of the services that we have available.
“Although having an increased risk of breast cancer means a woman is more likely to develop the disease – it’s by no means a certainty. A woman at high risk may never get breast cancer just as a woman at low risk still could. But any woman with concerns should speak to her GP to discuss the options.”
The Latest on: Breast cancer
via Google News
The Latest on: Breast cancer
- Buddy Check 3: Woman reflects on her battle with breast cancer 37 years lateron December 4, 2021 at 6:36 am
On Buddy Check 3 Day, WSAV News 3’s Tina Tyus-Shaw talked to a Savannah woman about battling a killer and using her voice to help save lives. “When I was 18, for ...
- Breast cancer researchers to be honored at symposiumon December 4, 2021 at 5:05 am
Representatives of San Antonio Breast Cancer Symposium and American Association for Cancer Research will honor two individuals for their significant contributions to breast cancer research. Helen M.
- Gene test spots breast cancer patients who can skip post-op chemoon December 4, 2021 at 12:05 am
A genetic test can identify older breast cancer patients who can forgo chemotherapy after surgery, even if the cancer has spread to nearby lymph nodes, a large international clinical trial shows.
- Breast Cancer Research Foundation of Alabama exceeds $1.2 million investment in Alabama-based researchon December 3, 2021 at 11:10 am
This funding supports local breast cancer research projects across Alabama. The Breast Cancer Research Foundation of Alabama (BCRFA) today announced a total investment of $1,225,000 in Alabama-based ...
- CURE Media Group Announces Winners of Inaugural Metastatic Breast Cancer Heroes™ Recognition Programon December 3, 2021 at 7:23 am
CURE Media Group, the industry-leading multimedia platform devoted to cancer updates and research that reaches more than 1 million patients, survivors, and caregivers, is pleased to announce the ...
- My wife died of breast cancer. Now, it has me thinking of California’s End of Life Option Acton December 3, 2021 at 5:00 am
A husband reflects on his wife's death and California's End of Life Option Act, which allows patients to end their lives with a doctor’s aid. A revision of the law will make it easier to do so.
- Coverage That Kills – Breast Cancer Care Is Undermined By High Deductible Health Planson December 3, 2021 at 4:00 am
There are so many awful things about breast cancer. Here are two of them. (1) Receiving a diagnosis when your cancer is already advanced; (2) Not having enough money to pay for your treatment. Here is ...
- Breakthrough metastatic breast cancer treatment hits snagon December 2, 2021 at 9:09 am
The compound developed by a team at the University of Illinois Urbana-Champaign worked in just days, without reoccurrence of cancerous tumors or any noticeable side-effects.
- Early-stage Breast Cancer Patients Can Now Avoid Chemotherapyon December 1, 2021 at 6:19 pm
In the study, postmenopausal women with 1 to 3 positive nodes and Recurrence Score® results of 0 to 25 showed no benefit from chemotherapy after a median of five years of follow-up, meaning they can ...
- New machine learning model reduces uncertainty in detection of breast canceron December 1, 2021 at 4:38 pm
Breast cancer is the most common cancer with the highest mortality rate. Swift detection and diagnosis diminish the impact of the disease.
via Bing News